Comparison of Thoracic Paravertebral Block , Pectoral Nerve Block to Serratus Anterior Plane Block in Breast Surgery, A Randomized Controlled Study
A Randomized Controlled Study Comparing Thoracic Paravertebral Block to Serratus Anterior Plane Block in Breast Surgery
1 other identifier
interventional
30
1 country
2
Brief Summary
The investigators hypothesize that the analgesic efficacy of ultrasound-guided serratus anterior plane block will provide better analgesia with fewer complications in comparison to ultrasound guided thoracic paravertebral block
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for not_applicable
Started Jan 2018
Shorter than P25 for not_applicable
2 active sites
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
December 29, 2017
CompletedStudy Start
First participant enrolled
January 4, 2018
CompletedPrimary Completion
Last participant's last visit for primary outcome
February 8, 2018
CompletedStudy Completion
Last participant's last visit for all outcomes
February 12, 2018
CompletedFirst Posted
Study publicly available on registry
March 5, 2018
CompletedMarch 16, 2018
March 1, 2018
1 month
December 29, 2017
March 14, 2018
Conditions
Outcome Measures
Primary Outcomes (1)
First pain medication request
Time to the first pain medication request till application of the block
24 hours
Secondary Outcomes (4)
Time of pain onset
24 hours
Hemodynamics (heart rate)
24 hours
Hemodynamics (ABP)
24 hours
Nausea and vomiting
24 hours
Study Arms (2)
Group I:
ACTIVE COMPARATORThese patients will receive single ipsilateral Ultrasound TPVB which performed with the patient in the sitting position at the level of the T4 with the probe in a vertical position 2.5-3 cm lateral to the midline. The midpoint of the transducer is to be placed in a longitudinal paramedian plane between two transverse processes which visualized with the superior costo-transverse ligament and the pleura visible in between . After this, 15-20 cc of bupivacaine 0.25% will be injected
Group II :
ACTIVE COMPARATORThese patients will receive serratus anterior plane block. The block will be performed while the patient is in the supine position by using a linear Ultrasound probe of high frequency (6-13 MHz) after sheathing. The probe will be placed over the mid-clavicular region of the thoracic cage in a sagittal plane. The ribs will be counted inferiorly and laterally, until the 5th rib is identified in the midaxillary line. The latissimus dorsi (superficial and posterior) , teres major (superior) and serratus muscles (deep and inferior) will be then easily identifiable by U/S overlying the fifth rib.
Interventions
Thoracic paravertebral block group (TPVB) group: The midpoint of the transducer is to be placed in a longitudinal paramedian plane between two transverse processes.Tuohy needle will be introduced in a cephalad direction. The tip of the needle will be advanced under direct visualization until it pierces the superior costo-transverse ligament. When the needle tip is located immediately above the pleura, the needle is aspirated to confirm the absence of blood or air. Serratus anterior plane block group (SAP) group: The US probe will be placed over the mid-clavicular region of the thoracic cage in a sagittal plane. The ribs will be counted until the 5th rib is identified in the midaxillary line. The latissimus dorsi, teres major and serratus muscles will be then easily identifiable by US overlying the fifth rib. The needle will be introduced in-plane with respect to the US probe from supero-anterior to postero-inferior
Eligibility Criteria
You may qualify if:
- Female patients
- Breast surgery with or without axillary clearance.
- Age from 20 to 60 years.
- ASA I, II, III.
You may not qualify if:
- Major reconstructive breast surgery.
- Age younger than 20 or older than 60 years.
- ASA IV, V.
- Hypersensitivity to any drug to be used.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Cairo Universitylead
- Mohamed, Ahmed A., M.D.collaborator
- Laila Halim Dosscollaborator
- Ahmed Zaghloul Fouadcollaborator
- Michael Zarif Sobhycollaborator
Study Sites (2)
Ahmed Abdalla Mohamed
Cairo, 11451, Egypt
Kasr Alainy Hospitals
Cairo, 11451, Egypt
MeSH Terms
Interventions
Intervention Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Ahmed Abdalla, M.D
Cairo University
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- DOUBLE
- Who Masked
- PARTICIPANT, CARE PROVIDER
- Masking Details
- •Patients will be randomly allocated to one of the two groups by sealed closed envelop technique
- Purpose
- SUPPORTIVE CARE
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Assistant Professor of Anesthesia &I.C.U and Pain Clinic
Study Record Dates
First Submitted
December 29, 2017
First Posted
March 5, 2018
Study Start
January 4, 2018
Primary Completion
February 8, 2018
Study Completion
February 12, 2018
Last Updated
March 16, 2018
Record last verified: 2018-03
Data Sharing
- IPD Sharing
- Will not share
Via scholar Gate